Cargando…
Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis
BACKGROUND: There is widespread, increasing use of magnesium sulphate in obstetric practice for pre-eclampsia, eclampsia, and preterm fetal neuroprotection; benefit for preventing preterm labour and birth (tocolysis) is unproven. We conducted a systematic review and meta-analysis to assess whether a...
Autores principales: | Shepherd, Emily, Salam, Rehana A., Manhas, Deepak, Synnes, Anne, Middleton, Philippa, Makrides, Maria, Crowther, Caroline A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897495/ https://www.ncbi.nlm.nih.gov/pubmed/31809499 http://dx.doi.org/10.1371/journal.pmed.1002988 |
Ejemplares similares
-
Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review
por: Bain, Emily S, et al.
Publicado: (2013) -
Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis
por: Crowther, Caroline A., et al.
Publicado: (2017) -
Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework
por: Bain, Emily, et al.
Publicado: (2015) -
Magnesium sulphate at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - study protocol
por: Crowther, Caroline A, et al.
Publicado: (2013) -
Effect of antenatal magnesium sulphate on MRI biomarkers of white matter development at term equivalent age: The magnum study
por: Poppe, Tanya, et al.
Publicado: (2020)